Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix Awarded Two US Patents UV LED Curing

7 Mar 2019 07:00

RNS Number : 9468R
ProPhotonix Limited
07 March 2019
 

 

 

March 7, 2019

ProPhotonix Limited

("ProPhotonix" or "the Company")

 

ProPhotonix Awarded Two US Patents for its Innovative UV LED Curing Systems

COBRA Cure FX Series unique features for ease of operation recognized.

ProPhotonix Limited (London Stock Exchange - AIM: PPIX, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, is pleased to announce that the United States Patent and Trademark Office has issued two US Patents for its COBRA Cure FX UV LED Curing Systems designed for use in UV curing applications in industrial printing, 3D printing and adhesives curing.

The first patent was awarded for the COBRA Cure FX series' innovative replaceable window that facilitates the quick removal and cleaning or outright replacement of the window without the need for special tools (US10180248). In some applications, a build-up of material can occur on the exit window of the lamps that can reduce light output. In order to limit machine downtime to clean or replace the lamps, this invention allows for fast replacement of the window, minimizing any downtime for users.

A second patent was awarded for an innovative sensing network for early detection of issues that may occur during the normal operation of the lamp that could impact system performance (US10180249). This sensing network ensures reliable operation for our customers while providing early detection of issues that can lead to automatic shutdown of the lamp or a message to the user that a fault has been detected.

Tim Losik, CEO, commented "Innovation is a cornerstone of ProPhotonix' offering to our customers and the Company continues to build it's Intellectual Property portfolio. The COBRA Cure FX series was developed in close cooperation with users and incorporates a number of novel user-centric features. We are proud to be able to offer this technology to improve product consistency and safety for our customers."

To see the full range of UV LED Curing Systems, visit: https://www.prophotonix.com/led-and-laser-products/uv-led-curing-systems/

 

Enquiries:

ProPhotonix Limited

sales@prophotonix.com

Tim Losik, President and CEO

Tel: +1 603 893 8778

Cantor Fitzgerald Europe

(Nominated Adviser and Broker)David ForemanRichard Salmond

 

Tel: +44 (0)207 894 7000

 

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI and Panasonic. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAZMGGFRKRGLZM
Date   Source Headline
13th Aug 20127:00 amRNSHalf Yearly Report
25th May 20122:30 pmRNSGrant of Options (Replacement)
17th May 20127:00 amRNSAGM Statement
1st May 20124:21 pmRNSPosting of Annual Report and Accounts
5th Apr 20127:00 amRNSAppointment of Three New Distribution Partners
26th Mar 20127:00 amRNSGrant of Options
19th Mar 20127:00 amRNSAppointment of Joint Broker
1st Mar 20127:00 amRNSFinal Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
19th Jan 20127:00 amRNSTrading Update and New Product Launch
27th Oct 20117:00 amRNS3rd Quarter Results
28th Jul 20117:00 amRNSHalf Yearly Report
20th Jul 20117:00 amRNSNotice of Results
13th Jul 20117:00 amRNSIssue of Equity
26th May 20111:51 pmRNSDirector/PDMR Shareholding
24th May 20115:09 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSChange of Adviser
4th May 20117:00 amRNS1st Quarter Results
19th Apr 20115:28 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.